IN8bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	36	44	57	82	-
Market Cap Growth	57.56%	-22.00%	-31.25%	-	-
Enterprise Value	28	28	44	48	-18
PE Ratio	-	-1.47	-1.98	-5.62	-
PB Ratio	2.04	1.77	2.49	2.16	-
P/FCF Ratio	-2.12	-1.84	-2.03	-5.96	-
P/OCF Ratio	-2.14	-1.89	-2.35	-6.09	-
EV/EBITDA Ratio	-1.54	-1.01	-1.62	-3.44	1.74
EV/EBIT Ratio	-1.41	-0.93	-1.55	-3.26	1.72
EV/FCF Ratio	-1.82	-1.16	-1.59	-3.45	2.50
Debt / Equity Ratio	0.33	0.20	0.26	0.06	-0.01
Debt / EBITDA Ratio	-0.20	-0.18	-0.21	-0.17	-0.02
Debt / FCF Ratio	-0.24	-0.20	-0.21	-0.17	-0.02
Quick Ratio	3.39	3.95	3.12	16.41	7.00
Current Ratio	4.10	4.57	3.82	17.28	7.05
Return on Equity (ROE)	-151.40%	-147.70%	-102.10%	-141.60%	80.10%
Return on Assets (ROA)	-107.80%	-105.00%	-82.10%	-46.00%	-93.80%
Return on Capital (ROIC)	-133.93%	-100.59%	-99.70%	-36.10%	52.16%
Earnings Yield	-87.04%	-67.97%	-50.39%	-17.80%	-
FCF Yield	-67.47%	-54.23%	-49.16%	-16.78%	-
Buyback Yield / Dilution	-75.02%	-42.43%	-110.32%	-191.59%	-7.24%
Total Shareholder Return	-75.02%	-42.43%	-110.32%	-191.59%	-7.24%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).